PD, thanks for that information. They must have been itchy to get things going before gov’t coverage kicked in and did a little discounting.
Hard to say how effective that move has/will be because $150 a month is still rather pricey. But it may have gotten a few new customers.
What, to me, is a little more troublesome is when you say that at your pharmacy you have had several people discontinue V. Hopefully it is a cost issue and not something else and they come back when gov’t coverage kicks in.
Market Data 
Markets 
AI
